Sim HG - Search Results

1

Role of post-chemotherapy surgery in germ cell tumors.

Sim HG, Lange PH, Lin DW. Sim HG, et al. Urol Clin North Am. 2007 May;34(2):199-217; abstract ix. doi: 10.1016/j.ucl.2007.02.010. Urol Clin North Am. 2007. PMID: 17484925 Review.

2

Two-year outcome of unilateral sural nerve interposition graft after radical prostatectomy.

Sim HG, Kliot M, Lange PH, Ellis WJ, Takayama TK, Yang CC. Sim HG, et al. Urology. 2006 Dec;68(6):1290-4. doi: 10.1016/j.urology.2006.08.1064. Epub 2006 Dec 4. Urology. 2006. PMID: 17141842

3

Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.

Sim HG, Telesca D, Culp SH, Ellis WJ, Lange PH, True LD, Lin DW. Sim HG, et al. J Urol. 2008 May;179(5):1775-9. doi: 10.1016/j.juro.2008.01.016. Epub 2008 Mar 17. J Urol. 2008. PMID: 18343432

4

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes.

Gordon RR, Wu M, Huang CY, Harris WP, Sim HG, Lucas JM, Coleman I, Higano CS, Gulati R, True LD, Vessella R, Lange PH, Garzotto M, Beer TM, Nelson PS. Gordon RR, et al. Among authors: sim hg. PLoS One. 2014 Sep 8;9(9):e104271. doi: 10.1371/journal.pone.0104271. eCollection 2014. PLoS One. 2014. PMID: 25198178 Free PMC article. Clinical Trial.

5

The natural history of voiding function after robot-assisted laparoscopic radical prostatectomy.

Wang L, Chung SF, Yip SK, Lau WK, Cheng CW, Sim HG. Wang L, et al. Among authors: sim hg. Urol Oncol. 2011 Mar-Apr;29(2):177-82. doi: 10.1016/j.urolonc.2009.01.030. Epub 2009 Apr 11. Urol Oncol. 2011. PMID: 19362862

6

Renal cell carcinoma in young patients is associated with poorer prognosis.

Lee LS, Yuen JS, Sim HG. Lee LS, et al. Among authors: sim hg. Ann Acad Med Singap. 2011 Sep;40(9):401-6. Ann Acad Med Singap. 2011. PMID: 22065033 Free article.

7

Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.

Chiong E, Tay MH, Tan MH, Kumar S, Sim HG, Teh BT, Umbas R, Chau NM. Chiong E, et al. Among authors: sim hg. Lancet Oncol. 2012 Nov;13(11):e482-91. doi: 10.1016/S1470-2045(12)70433-3. Lancet Oncol. 2012. PMID: 23117003 Review.

8

Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma.

Yuen JS, Sim MY, Sim HG, Chong TW, Lau WK, Cheng CW, Ong RW, Huynh H. Yuen JS, et al. Among authors: sim hg. Int J Oncol. 2012 Aug;41(2):712-20. doi: 10.3892/ijo.2012.1494. Epub 2012 May 23. Int J Oncol. 2012. PMID: 22641227

9

Predictors of androgen independence in metastatic prostate cancer.

Sim HG, Lau WK, Cheng CW. Sim HG, et al. BJU Int. 2004 Jun;93(9):1221-4. doi: 10.1111/j.1464-410X.2004.04863.x. BJU Int. 2004. PMID: 15180610

10

Early experience with robot-assisted laparoscopic radical prostatectomy.

Sim HG, Yip SK, Lau WK, Tan JK, Cheng CW. Sim HG, et al. Asian J Surg. 2004 Oct;27(4):321-5. doi: 10.1016/S1015-9584(09)60060-9. Asian J Surg. 2004. PMID: 15564188 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters